MSCA

MSCA Cofund 2025: HORIZON-MSCA-2025-COFUND-01

The main objective of the MSCA COFUND 2025 call is to co-finance new or existing PhD programmes, as well as programmes for the incorporation of research staff at national, regional or international level. Through these actions, the aim is to promote the best practices of MSCAs, including training in international, intersectoral and interdisciplinary research, as well as to encourage transnational and sectoral mobility of researchers at all stages of their career.

Closing date: 24/06/2025

MSCA Postdoctoral Fellowships 2025: HORIZON-MSCA-2025-PF-01-01

Fellowships will be awarded to outstanding researchers pursuing international mobility. Applications must be submitted jointly by the researcher and a beneficiary entity from the academic or non-academic sector. Postdoctoral Fellowships can be carried out in Europe (i.e., in an EU Member State or a Horizon Europe Associated Country) or in a third country not associated with Horizon Europe:

• European Postdoctoral Fellowships: These are open to researchers of any nationality who wish to participate in R&D&I projects, whether coming to Europe from anywhere in the world or moving within Europe. The standard duration of these fellowships is between 12 and 24 months.

  
  

• Global Postdoctoral Fellowships: These are open to European nationals or long-term residents who wish to participate in R&D&I projects with organizations outside EU Member States and Horizon Europe Associated Countries. These fellowships require an initial period abroad of a minimum of 12 and a maximum of 24 months in a non-associated third country, and a mandatory 12-month return period to a host organization located in an EU Member State or Horizon Europe Associated Country.

  
  

  
  

Closing date: 10/09/2025

MSCA Staff Exchanges 2025: HORIZON-MSCA-2025-SE-01-01

MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from all over the world.

Support is provided for the international, intersectoral and interdisciplinary mobility of staff. R+D which promotes the transfer of knowledge between participating organizations.

Mobility through stays

The organizations that form the association contribute directly to the implementation of a joint project of R+D by sending and/or hosting eligible staff. Such a project should explore activities that can build on previous work, but should also go beyond that, generating or strengthening long-term collaborations. The placements should involve physical mobility of eligible staff members and should always take place between legal entities independent of each other.

Closing date: 08/10/2025

ERC

ERC PROOF OF CONCEPT GRANT 2025

These calls are intended to verify the innovative potential of ideas and results derived from projects already funded by ERC projects that are under development or that have been completed during the year prior to the opening date of this call.

Learn more.

Closing date: 18/09/2025

Cluster 1 Health - Single Stage

Destination - Tackling diseases and reducing disease burden

• HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

  
  

• HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

  
  

• HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response

  
  

• HORIZON-HLTH-2025-01-DISEASE-05: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)

  
  

• HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)

  
  

• HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and under-researched medical conditions

  
  

Destination - Ensuring equal access to innovative, sustainable, and high-quality healthcare

• HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)

  
  

Destination - Developing and using new tools, technologies and digital solutions for a healthy society

• HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques

  
  

• HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies

  
  

• HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)

  
  

• HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies

  
  

  
  

Destination - Maintaining an innovative, sustainable, and competitive EU health industry

• HORIZON-HLTH-2025-01-IND-01: Optimizing the manufacturing of Advanced Therapy Medicinal Products (ATMPs)

  
  

• HORIZON-HLTH-2025-01-IND-02: Digitalization of conformity assessment procedures of medical devices and in vitro diagnostic medical devices

  
  

Closing date for the first phase: 16/09/2025

Cluster 1 Health - Two Stage

Destination - Living and working in a health-promoting environment

• HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders

  
  

• HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health

  
  

Destination - Tackling diseases and reducing disease burden

• HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioral and neurodevelopmental disorders

  
  

  
  

Destination - Maintaining an innovative, sustainable, and competitive EU health industry

• HORIZON-HLTH-2025-03-IND-03-two-stage: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices

  
  

Destination - Staying healthy in a rapidly changing society

• HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families

  
  

Closing date for the second phase: 16/04/2026

CANCER MISSION WP2025

• HORIZON-MISS-2025-02-CANCER-01: Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational Research.

  
  

• HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of pediatric, adolescent and young adult cancers.

  
  

• HORIZON-MISS-2025-02-CANCER-03: Innovative surgery as the cornerstone of affordable multi-modal therapeutic interventions benefiting cancer patients with locally advanced or metastatic disease.

  
  

• HORIZON-MISS-2025-02-CANCER-04: Investigator-initiated multinational early-stage innovative clinical trials for pediatric cancer.

  
  

• HORIZON-MISS-2025-02-CANCER-05: Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition.

  
  

• HORIZON-MISS-2025-02-CANCER-06: Support to the network of National Cancer Mission Hubs (NCMHs).

  
  

Closing date: 16/09/2025

EIC

EIC Pathfinder 2025

The EIC Pathfinder is a funding program within Horizon Europe that provides support to research teams through:

• funding research to develop the scientific basis that supports revolutionary technologies,

  
  

• support for the earliest stages of scientific, technological or deep-tech R&D,

  
  

• the goal of driving new innovative directions in science and technology that can transform a field and a market, or create new opportunities,

  
  

• the implementation of innovative technological solutions to identify, develop, and scale groundbreaking technologies and disruptive innovations in Europe.

Learn more.

Deadline EIC Pathfinder Challenges: 29/10/2025

EIC Transition Open: HORIZON-EIC-2025-TRANSITIONOPEN

EIC Transition funds innovation activities that go beyond the experimental proof of concept in the laboratory. It supports both the maturation and validation of your novel technology, from the laboratory to relevant application environments (through the use of prototypes, formulations, models, user trials, or other validation tests), as well as the exploration and development of a sustainable business model and business case for commercialization.

Closing date: 17/09/2025

CanSERV - open call relaunches: apply now for free access to cutting-edge cancer research services

Through the EU-funded canSERV project, more than 400 advanced cancer research services and technologies are available to European and international researchers, regardless of their career stage.

These services can be combined with customized training opportunities or advisory services, helping scientists accelerate their research and bring new knowledge closer to clinical impact.

Information about the call, the submission of proposals and their evaluation is available upon request to calls@canSERV.eu.

Closing date: 15/07/2025

COST

COSTAction

COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks. Its actions help connect research initiatives across Europe and beyond, and allow researchers and innovators to develop their ideas in any field of science and technology by sharing them with their peers.

Participants planning to submit a proposal for a COST Action should refer to the SESA guidelines and the Open Call Announcement, available on the COST Action page. Documents and Guidelines.

Closing date: 21/10/2025

IHI

NNew draft text for the 11th IHI call

The Innovative Health Initiative (IHI) partnership is considering the following topics for inclusion in its 11th call for proposals.

• Understanding how infections promote and induce non-communicable diseases

  
  

• Towards precision medicine: a platform for transdiagnostic stratification of brain dysfunction

  
  

• AI-driven signal detection in pharmacovigilance

  
  

• Harnessing European expertise to accelerate cell therapy for type 1 diabetes

  
  

• Establishment of orthopedic and cardiology outpatient surgery centers in Europe

It will be in two phases and its launch is scheduled for 2025 second quarter.

Learn more.

Humboldt

Humboldt Research Fellowship

For Experienced Researchers 2024

The purpose of this call is to support highly qualified scientists for 6-18 months in their intention to carry out a postdoctoral training stay at a German centre, regardless of their area of ​​research.

For Postdoctoral Researchers 2024

This call for applications will help young PhD students who obtained their PhD less than four years ago to undertake long-term stays at a German institution for postdoctoral training.

The application period is open throughout the year, but the evaluation committee meets three times: in March, July and November.

09/06/2025

Webinar: Horizon Europe Missions and the New European Bauhaus: Updates and Calls for Proposals 2025

CDTI is organizing the virtual conference "Horizon Europe Missions and the New European Bauhaus (NEB)" to present the latest developments and content of the 2025 calls.

During the day, there will be a plenary session and six parallel sessions that will delve into the development of each of the Missions and the 2025 calls for proposals. For the first time, a parallel session will be held to report on the latest developments in the NEB initiative.

Parallel Session 1: "A European Pact for Soil"

Parallel Session 2: "Oceans and Waters Mission"

Parallel Session 3: "Climate Change Adaptation Mission"

Parallel Session 4: "Mission Cities"

Parallel Session 5: "Mission Cancer"

Parallel Session 6: “New European Bauhaus”

More information and registration.

10/06/2025

National information day on the European Cooperation in Science and Technology Programme "COST"

The Ministry of Science, Innovation and Universities (MICIU) and the European Office of FECYT are holding a National Information Day to disseminate the European Cooperation in Science and Technology (COST) Program.

This event will be held on June 10th in person at the MICIU (Room A, 2nd floor). The event will feature presentations by the national delegate to the COST Senior Representatives Committee and the COST National Coordinator to present the COST program, the results of the 2024 call for proposals, and the latest developments in the 2025 call for proposals.

The main objective of the conference is to promote the participation of Spanish researchers in the COST Program and to explain the latest developments within the Horizon Europe research framework program. The aim is to provide guidance for developing a successful proposal and to address issues of interest within the COST community, such as the implications of assuming the role of Grant Holder.

Learn more.

12/06/2025

Info Day “European Health Funding 2025: Challenges and Opportunities”

The Navarrabiomed biomedical research center and Navarra Health Cluster are organizing Info Day on Thursday, June 12: "European Funding in Health 2025: Challenges and Opportunities." This event is aimed at researchers, companies, and organizations looking to boost their health projects through European funding.

The Info Day will take place at Navarrabiomed headquarters from 10:00 a.m. to 17:00 p.m. Discover the key aspects of the Horizon Europe Program, the Cancer Mission, the new Innovative Health Initiative (IHI) call for proposals, and learn from real-life success stories. Plus, enjoy networking opportunities, lunch, and B2B meetings with NCPs.

Link to the program and registration.

16/06/2025

EP PerMed Implementation School on personalized medicine: “Data-driven research and implementation”

Training event dedicated to advancing research and implementation of personalized medicine.

The event aims to foster a culture of application-focused research and provide participants with practical knowledge and strategies for integrating personalized medicine into the real world.

It will take place in Zaragoza (Spain) from November 4 to 7, 2025.

More information in the following link.

17/06/2025

European Health Research Infrastructures Conference

The conference aims to inform the public about the role of European Research Infrastructures and the services they offer to the scientific community in developing top-quality research. The conference is structured into a series of introductory sessions and three roundtables that will discuss topics of interest such as the contribution of Research Infrastructures to the European Data Space and the challenges faced by the Spanish nodes of some of the health Research Infrastructures. Success stories that serve as examples of the possible uses of these Research Infrastructures will also be presented.

In-person session, free attendance until capacity is reached.

Learn more.

18/06/2025

Lump Sum Funding in Horizon Europe: Quick overview of the main features

On June 18, the European Commission will hold a new information day dedicated to the lump sum financing in Horizon Europe.

During the session, we'll explain how this form of financing works and what to consider when writing a proposal. There will also be a dedicated space for audience questions.

The event will be broadcast live over the Internet and registration is not necessary to participate.

All information about the event is available at the European Commission website.

19/06/2025  

Webinar: How to become an expert for Horizon Europe

The European Commission (EC) is organizing this webinar dedicated to providing information to those who wish to participate as experts in Horizon Europe, either as proposal evaluators or to monitor funded projects.

Information will be provided on Horizon Europe, the different roles that experts can play, and the experience needed in different areas.

Learn more.

24/06/2025

Webinar: MSCA Doctoral Networks

Doctoral Networks are a key component of the Marie Skłodowska-Curie Actions. There are three implementation modalities:

• Standard Doctoral Networks (RD)

• Joint Doctorates (JD)

• Industrial Doctorates (ID).

The goal is to inform all potential applicants and interested parties about the important requirements for 2025 and promote the DI and DJ modalities. Participants will have the opportunity to ask questions via Slido, both in advance of the event (starting May 29, 2025) and during the Q&A session.

Learn more.

26/06/2025

National information day on legal and financial issues of Horizon Europe

The team of National Contact Points (NCPs) for legal and financial matters related to Horizon Europe is organizing a national conference in a hybrid format that will feature testimonies from the European Commission and several Spanish participants on topics related to some of the new features in the Rules of Participation and the first audits of Horizon Europe projects.

The event will be held on Thursday 26 June in the CSIC auditorium, Calle Serrano 117, Madrid. Those who wish to follow the event online can do so through Horizon Europe YouTube channel.

The agenda of the day and the registration form are available at the CDTI events portal.

For any questions, please contact: infodesk@sost.be

28/10/2025

EACR-OECI: Patient Involvement in Cancer Research

The patient perspective in cancer research is vital to creating more effective, compassionate, and equitable research that truly benefits those affected by the disease. Patient focus organizations are working on empowering patients to actively participate in decision-making, treatment planning, and research design, fostering better outcomes and relevance, but there is still work to be done. By actively incorporating patients' perspectives, research can better address key aspects of cancer care, such as patients' quality of life, symptom management, and treatment side effects. Patients can also highlight gaps in communication and in current treatment options or areas where existing therapies fall short, leading to the development of innovative approaches to care.

This virtual event, a collaboration between the EACR and the OECI (Organisation of European Cancer Institutes), will explore how meaningful involvement of cancer advocates throughout the research process can lead to impactful cancer research.

Learn more.